INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-22 Cr | ₹92 Cr | ₹361 Cr | ₹27 Cr | ₹125 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-22 Cr |
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹361 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹125 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-22 Cr | Negative | |
| Mar2025 | ₹92 Cr | -74.63 | |
| Mar2024 | ₹361 Cr | 1,231.88 | |
| Mar2023 | ₹27 Cr | -78.25 | |
| Mar2022 | ₹125 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹6,671.0 Cr | 0.7% | -0.7% | 33.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 0.7% |
-0.7% |
33.9% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses